Photo: The Hindu Business
Business & Finance
Aurobindo Pharma Q2 net up 32.5% to ₹1,124 cr on higher revenue
TL;DR
- The strong performance the company has delivered in Q2 reflected the strength of the business fundamentals, sustained execution and the resilience of its diversified product portfolio.
Short summary
Our full write-up is on its way. For the complete story, read the original report:
Nov 5, 2026 · Updated 11/5/2026, 11:24:13 AM · Reported with: The Hindu Business
Sources (1)
NRI Bytes writes its own articles from the reporting below.
The Hindu Business — Aurobindo Pharma Q2 net up 32.5% to ₹1,124 cr on higher revenueUp next · Business & Finance
Chinese AI lab Moonshot turned to Europe for Nvidia Blackwell access amid U.S. China curbs, sources tell CNBC
Read next →
More stories
Business & Finance
Sebi tightens rupee derivative norms to align with RBI's $5 million threshold
43m ago
Business & Finance
PFC dividend: Up 200% in 5 yrs, Maharatna PSU's shares rally 5% in 3 days - Check dividend record date, payment timeline
59m ago
Business & Finance
CBC to broaden personal finance programming with launch of CBC Money
59m ago
Business & Finance
BCE’s free cash flow falls as it boosts spending on AI data centres, U.S. fibre networks
1h ago
